| Action | Requirements for use of central fill pharmacy and remote database access |
| Stage | Proposed |
| Comment Period | Ends 12/18/2026 |
![]() |
2 comments
Hello,
Respectfully writing regarding 18VAC110-20-277 Section B 3. Limiting a central fill facility to schedule VI drugs prohibits the filling of necessary chronic meds (ex: anti-seizure) and complicates the logistics of providing these meds to patients, many who are able to get their other schedule VI meds delivered via mail order or courier but will now need to find a different path to obtain something controlled. This will impact a patients access to medications in the current climate where we are combating pharmacy deserts. Consider opening up to schedule III-V. the increased risk of diversion that is likely the reason for this exclusion can still be balanced with tightened diversion prevention requirements and additional monitoring in these facilities. Note that other states allow this practice and CFR 1306.27 allows the transfer of CIII, IV, and V to a central fill pharmacy.
Hello.
One item that I don't believe is addresssed in pharmacy regulations, nor these central fill regulations, is the concept of owner accountability. There is a significant load of accountabiltiy placed on the PIC and other pharmacists for the practices, but ultimately no reflection on the corporate ownership. Despite credence to the pharmacist having the explicit ability to limit the numebr of indiviudals under thier pruview, we all know that corporations set policies and have undue influence.